TY - JOUR
T1 - A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
AU - Centola, Marco
AU - Lucreziotti, Stefano
AU - Salerno-Uriarte, Diego
AU - Sponzilli, Carlo
AU - Ferrante, Giulia
AU - Acquaviva, Roberta
AU - Castini, Diego
AU - Spina, Marianna
AU - Lombardi, Federico
AU - Cozzolino, Mario
AU - Carugo, Stefano
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Background Contrast-induced acute kidney injury (CI-AKI) is associated with significantly increased mortality after primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI). The prognostic value of CI-AKI depends on the definitions used to define it. We compare the predictive accuracy of long-term mortality of two definitions of CI-AKI on consecutive patients undergoing pPCI for STEMI. Methods Incidence, risk factors and long-term prognosis of CI-AKI were assessed according to two different definitions: the first as an increase in serum creatinine ≥ 25% or ≥ 0.5 mg/dl from baseline within 72 h after pPCI (contrast-induced nephropathy (CIN) criteria), the second one according to Acute Kidney Injury Network (AKIN) classification system. Results A total of 402 patients were enrolled. The median follow-up period was 12 ± 4 months. Long-term mortality rate was 9.5%. Independent predictors of long-term mortality were: older age, basal renal impairment, left ventricular ejection fraction <40%, in-hospital major bleedings and CI-AKI. A significant correlation was found between mortality and CI-AKI as assessed by both CIN (HR 4.84, 95% CI: 2.56-9.16, p = 0.000) and AKIN (HR 9.70, 95% CI: 5.12-18.37, p = 0.000) definitions. The area under the receiver operating curve was significantly larger for predicting mortality with AKIN classification than with CIN criteria (0.7984 versus 0.7759; p = 0.0331). Conclusions In patients with STEMI treated by pPCI, CI-AKI is a frequent complication irrespective of the criteria used for its definition. AKIN, however, seems to provide a better accuracy in predicting long-term mortality than CIN criteria.
AB - Background Contrast-induced acute kidney injury (CI-AKI) is associated with significantly increased mortality after primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI). The prognostic value of CI-AKI depends on the definitions used to define it. We compare the predictive accuracy of long-term mortality of two definitions of CI-AKI on consecutive patients undergoing pPCI for STEMI. Methods Incidence, risk factors and long-term prognosis of CI-AKI were assessed according to two different definitions: the first as an increase in serum creatinine ≥ 25% or ≥ 0.5 mg/dl from baseline within 72 h after pPCI (contrast-induced nephropathy (CIN) criteria), the second one according to Acute Kidney Injury Network (AKIN) classification system. Results A total of 402 patients were enrolled. The median follow-up period was 12 ± 4 months. Long-term mortality rate was 9.5%. Independent predictors of long-term mortality were: older age, basal renal impairment, left ventricular ejection fraction <40%, in-hospital major bleedings and CI-AKI. A significant correlation was found between mortality and CI-AKI as assessed by both CIN (HR 4.84, 95% CI: 2.56-9.16, p = 0.000) and AKIN (HR 9.70, 95% CI: 5.12-18.37, p = 0.000) definitions. The area under the receiver operating curve was significantly larger for predicting mortality with AKIN classification than with CIN criteria (0.7984 versus 0.7759; p = 0.0331). Conclusions In patients with STEMI treated by pPCI, CI-AKI is a frequent complication irrespective of the criteria used for its definition. AKIN, however, seems to provide a better accuracy in predicting long-term mortality than CIN criteria.
KW - Contrast-induced acute kidney injury
KW - Myocardial infarction
KW - Primary angioplasty
UR - http://www.scopus.com/inward/record.url?scp=84964608825&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964608825&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2016.02.086
DO - 10.1016/j.ijcard.2016.02.086
M3 - Article
AN - SCOPUS:84964608825
SN - 0167-5273
VL - 210
SP - 4
EP - 9
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -